Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-15 Sale(A) | 2022-02-11 9:41 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 41,306 | $68.49 | $2,829,152 | 999,914 (Indirect Direct) | View |
| 2020-06-11 Sale(A) | 2022-02-11 9:40 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 50,953 | $65.19 | $3,321,623 | 1,139,915 (Indirect Direct) | View |
| 2021-11-29 Sale | 2021-12-01 7:24 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 24,525 | $112.8 | $2,766,433 | 1,496,650 (Indirect Direct) | View |
| 2021-11-16 Sale | 2021-11-17 7:03 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 37,740 | $116.65 | $4,402,385 | 1,521,175 (Indirect Direct) | View |
| 2020-06-15 Sale | 2020-06-17 9:55 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 140,000 | $67.37 | $9,431,750 | 999,915 (Indirect Direct) | View |
| 2020-06-11 Sale | 2020-06-12 8:09 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 160,000 | $64.07 | $10,251,053 | 1,139,915 (Indirect Direct) | View |
| 2019-04-12 Sale | 2019-04-16 7:23 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 88,825 | $58.42 | $5,189,444 | 1,299,915 (Indirect Direct) | View |
| 2019-03-22 Sale | 2019-03-26 6:30 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 11,175 | $53.69 | $600,000 | 1,388,740 (Indirect Direct) | View |
| 2019-02-27 Sale | 2019-03-01 5:59 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 101,024 | $46.26 | $4,672,922 | 1,399,915 (Indirect Direct) | View |
| 2019-02-22 Sale | 2019-02-26 5:44 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 76,898 | $44.9 | $3,452,588 | 1,500,939 (Indirect Direct) | View |
| 2019-02-15 Sale | 2019-02-20 5:40 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 2,078 | $45.48 | $94,509 | 1,577,837 (Indirect Direct) | View |
| 2019-02-12 Sale | 2019-02-14 4:42 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 40,000 | $44.31 | $1,772,307 | 1,579,915 (Indirect Direct) | View |
| 2018-12-03 Sale | 2018-12-06 4:26 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 40,000 | $41.95 | $1,678,000 | 1,619,915 (Indirect Direct) | View |
| 2018-06-04 Sale | 2018-06-06 4:19 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 89,216 | $35.25 | $3,145,112 | 1,659,915 (Indirect Direct) | View |
| 2018-05-30 Sale | 2018-06-01 5:29 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 110,784 | $35.03 | $3,881,056 | 1,749,131 (Indirect Direct) | View |
| 2018-01-16 Sale | 2018-01-18 6:57 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 128,058 | $26.95 | $3,451,297 | 1,859,915 (Indirect Direct) | View |
| 2018-01-10 Sale | 2018-01-12 7:00 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 121,942 | $26.78 | $3,265,537 | 1,178,058 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 170,000 | $0 | 1,308,989 (Indirect) | View |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 1,474,051 | $0 | 1,308,989 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 0 | $0 | 1,308,989 (Indirect) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 175,000 | $5.6 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $28.76 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $47.1 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 50,000 | $9.29 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 30,000 | $10.82 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A 2024-11-25 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 559,000 | $0 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 250,000 | $0.61 | 1,521,175 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 7:03 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $61.76 | 1,521,175 (Direct) | View |
| 2021-06-30 Gift | 2021-08-11 4:30 pm | N/A N/A | TENAX THERAPEUTICS Inc | TENX | Doogan Declan Director 10% Owner | 567,871 | $0 | 3,070,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-15 4:34 pm | 2022-06-10 2031-06-10 | TENAX THERAPEUTICS Inc | TENX | Doogan Declan Director 10% Owner | 6,250 | $0 | 3,644,121 (Direct) | View |
| 2021-06-10 Exercise | 2021-06-15 4:34 pm | 2021-06-11 2021-06-11 | TENAX THERAPEUTICS Inc | TENX | Doogan Declan Director 10% Owner | 3,073,070 | $0 | 3,644,121 (Direct) | View |
| 2021-02-25 Ownership | 2021-06-15 4:33 pm | N/A N/A | TENAX THERAPEUTICS Inc | TENX | Doogan Declan Director | 0 | $0 | 570,941 (Direct) | View |
| 2021-05-05 Option Award | 2021-05-07 4:34 pm | N/A 2031-05-04 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 11,996 | $0 | 11,996 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-01 9:14 pm | N/A 2030-04-29 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-23 6:33 pm | N/A 2029-05-20 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2018-05-01 Option Award | 2018-05-03 5:25 pm | N/A 2028-04-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 18,000 | $0 | 18,000 (Direct) | View |